Immunopathology in ocular toxoplasmosis: facts and clues

by Justus G Garweg, Ermanno Candolfi
Published 2009-03-01

Treatment Strategy in Human Ocular Toxoplasmosis: Why Antibiotics Have Failed

by Justus G. Garweg, Uwe Pleyer
Published 2021-03-01

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes

by Christof Haensli, Isabel B. Pfister, Justus G. Garweg
Published 2021-06-01

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review

by Arthur Baston, Christin Gerhardt, Souska Zandi, Justus G. Garweg
Published 2021-05-01

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus

by Lucia Saucedo, Isabel B. Pfister, Souska Zandi, Christin Gerhardt, Justus G. Garweg
Published 2021-01-01

Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration.

by Jan Spindler, Souska Zandi, Isabel B Pfister, Christin Gerhardt, Justus G Garweg
Published 2018-01-01

Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma.

by Justus G Garweg, Souska Zandi, Isabel B Pfister, Magdalena Skowronska, Christin Gerhardt
Published 2017-01-01

Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase...

by Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr Kolar
Published 2020-01-01

Biomarkers for PVR in rhegmatogenous retinal detachment.

by Souska Zandi, Isabel B Pfister, Peter G Traine, Christoph Tappeiner, Alain Despont, Robert Rieben, Magdalena Skowronska, Justus G Garweg
Published 2019-01-01